Ribonucleotide reductase drugs for Sickle Cell Disease
3 tracked Ribonucleotide reductase drugs in the Sickle Cell Disease race. The class explanation lives on the Ribonucleotide reductase page; the full indication pipeline across every mechanism is on the Sickle Cell Disease page.
3 approved / phase 4
Head-to-head evidence: Hydroxyurea (Droxia) vs Hydroxyurea (Xromi) · Hydroxyurea (Siklos) vs Hydroxyurea (Xromi)